Publikace
- Heart failure in Fabry disease revisited: application of current heart failure guidelines and recommendations2022 | 1. lékařská fakulta
- Normative reference ranges for echocardiographic chamber dimensions in a healthy Central European population: results from the Czech post-MONICA survey2019 | 1. lékařská fakulta
- Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease (vol 11, e0166290, 2016)2017 | 1. lékařská fakulta
- Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease2016 | 1. lékařská fakulta
- Regression of acromegalic left ventricular hypertrophy after lanreotide (a glow-release somatostatin analog)1999 | 1. lékařská fakulta
- Long-term clinical outcomes and left ventricular reverse remodeling in recently diagnosed unexplained delated cardiomyopathy2024 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu
- Does Secondary Antibiotic Prophylaxis Improve Clinical Outcomes in Adult Rheumatic Heart Disease Patients Post-Valve Replacement?2023 | 1. lékařská fakulta
- A unique case of extensive myocardial late iodine enhancement on CT in Anderson-Fabry disease2023 | 1. lékařská fakulta
- Three-dimensional echocardiographic left ventricular strain analysis in Fabry disease: correlation with heart failure severity, myocardial scar, and impact on long-term prognosis2023 | 1. lékařská fakulta
- The Impact of Atrial Fibrillation and Atrial Tachycardias on the Hemodynamic Status of Patients with Pulmonary Hypertension2022 | 1. lékařská fakulta
Loading network view...